Acute Myocardial Infarction Pipeline Highlights – 2017 Update

1. Acute Myocardial Infarction Pipeline by Stages

2. Acute Myocardial Infarction Pipeline by Drug Class

3. Acute Myocardial Infarction Pipeline by Company

4. Acute Myocardial Infarction Phase 3 Clinical Trial Insights

5. Acute Myocardial Infarction Phase 2 Clinical Trial Insights

6. Acute Myocardial Infarction Phase 1 Clinical Trial Insights

7. Acute Myocardial Infarction Preclinical Research Insights

8. Acute Myocardial Infarction Discovery Stage Insights

9. Appendix

10. Research Methodology

LIST OF TABLES

Table 1: Acute Myocardial Infarction Phase 3 Clinical Trials, 2017

Table 2: Acute Myocardial Infarction Phase 2 Clinical Trials, 2017

Table 3: Acute Myocardial Infarction Phase 1 Clinical Trials, 2017

Table 4: Acute Myocardial Infarction Preclinical Research, 2017

Table 5: Acute Myocardial Infarction Discovery Stage, 2017

LIST OF FIGURES

Figure 1: Acute Myocardial Infarction Pipeline Molecules by Clinical Trials Stage, 2017

Figure 2: Acute Myocardial Infarction Pipeline Molecules by Drug Class, 2017

Figure 3: Acute Myocardial Infarction Pipeline Molecules by Company, 2017

Figure 4: Acute Myocardial Infarction Phase 3 Clinical Trial Highlights, 2017

Figure 5: Acute Myocardial Infarction Phase 2 Clinical Trial Highlights, 2017

Figure 6: Acute Myocardial Infarction Phase 1 Clinical Trial Highlights, 2017

Figure 7: Acute Myocardial Infarction Preclinical Research Highlights, 2017

Figure 8: Acute Myocardial Infarction Discovery Stage Highlights, 2017

Acute Myocardial Infarction Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Acute Myocardial Infarction Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Acute Myocardial Infarction market. It covers emerging therapies for Acute Myocardial Infarction in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Acute Myocardial Infarction pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Acute Myocardial Infarction pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Acute Myocardial Infarction pipeline products by the company.

Short-term Launch Highlights:
Find out which Acute Myocardial Infarction pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

• Acute Myocardial Infarction phase 3 clinical trial pipeline products
• Acute Myocardial Infarction phase 2 clinical trial pipeline products
• Acute Myocardial Infarction phase 1 clinical trial pipeline products
• Acute Myocardial Infarction preclinical research pipeline products
• Acute Myocardial Infarction discovery stage pipeline products
• Acute Myocardial Infarction pipeline products short-term launch highlights